Detection of areas with viable remnant tumor in postchemotherapy patients with Ewing’s sarcoma by dynamic contrast-enhanced MRI using pharmacokinetic modeling
- 1 June 2000
- journal article
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 18 (5) , 525-535
- https://doi.org/10.1016/s0730-725x(00)00144-2
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Detection of Bone Tumours in Radiographic Images using Neural NetworksPattern Analysis and Applications, 1999
- Musculoskeletal tumors: does fast dynamic contrast-enhanced subtraction MR imaging contribute to the characterization?Radiology, 1998
- Does magnetic resonance imaging make a difference for patients with musculoskeletal sarcoma?The British Journal of Radiology, 1997
- Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery.American Journal of Roentgenology, 1995
- Pharmacokinetic Mapping of the Breast: A New Method for Dynamic MR MammographyMagnetic Resonance in Medicine, 1995
- Classification of histopathologic changes following chemotherapy in Ewing's sarcoma of boneSkeletal Radiology, 1994
- Monitoring the effect of chemotherapy in Ewing's sarcoma of bone with MR imagingSkeletal Radiology, 1994
- MR imaging of edema accompanying benign and malignant bone tumorsSkeletal Radiology, 1994
- Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental conceptsMagnetic Resonance in Medicine, 1991
- Proton Relaxation Times in Paramagnetic SolutionsThe Journal of Chemical Physics, 1957